AI in Healthcare Advances Further: DeepWise Medical Unveils Three New Products at CHINA MED

VCBeat (WeChat ID: vcbeat) has learned that the 31st China International Medical Equipment Fair (CHINA MED) was held from March 22 to 24, 2019, at the China National Convention Center in Beijing. As one of the largest exhibitions in the healthcare industry, CHINA MED has long served as a showcase platform for new medical products and technologies in China, attracting more than 50,000 professional visitors from over 40 countries and regions each year. At this year’s CHINA MED, the participation of artificial intelligence companies undoubtedly added a bright spot to the traditional medical exhibition.

CHINA MED DeepWise Booth

As the only renowned artificial intelligence enterprise exhibiting at this expo, DeepWise made a strong presence with its full range of products and solutions, including its flagship offerings: the Dr. Wise® AI-assisted medical diagnosis system, Dr. Wise® Cloud intelligent imaging cloud platform, and Dr. Wise® Radiomics multimodal research platform.

Three new products were launched at the exhibition: Dr. Wise® AI Assessment System for Children’s Growth and Development 2.0, Dr. Wise® AI-Assisted Diagnostic System for Stroke 3.0, and Dr. Wise® AI-Assisted Diagnostic System for Chest Radiography. These new products can be widely applied in various areas, including assisted diagnosis of stroke, assessment of children’s growth and development, and screening for chest diseases. By leveraging deep learning technologies and core algorithms from DeepWise Research Institute, they provide diverse possibilities for further clinical examinations, helping physicians improve diagnostic accuracy and efficiency. The product launch attracted significant media attention and strong industry response, drawing numerous professional visitors to the booth for discussions and exchanges.

DeepWise CEO and Co-Founder Qiao Xin Accepts Media Interview

At the 9th Forum on Technological Advances and Clinical Applications of High-End Imaging Equipment, held concurrently with the exhibition, Li Chaoyang, Senior Vice President of DeepWise, delivered a keynote address titled “Opportunities and Challenges Brought by Artificial Intelligence to Hospitals.” He engaged with attending experts in a discussion on the current status and challenges of AI in the healthcare industry. With the advancement of new AI technologies, the discussion focused on how physicians can leverage the technical capabilities of AI to collaborate with enterprises in expanding clinical application scenarios, thereby better serving patients and improving the accuracy and efficiency of diagnosis and treatment.

Li Chaoyang, Senior Vice President of DeepWise

Healthy growth and development in children is the hope of every family. The Dr. Wise® AI Assessment System for Pediatric Growth and Development helps physicians and parents better monitor children's growth and developmental progress, enabling early clinical intervention for children with developmental abnormalities.

On display is the Dr. Wise® AI Assessment System 2.0 for Pediatric Growth and Development, which adopts the internationally widely accepted TW3 standard and the China-05 standard based on Chinese pediatric samples. Featuring advanced, systematic, and comprehensive capabilities—including intelligent identification and grading of target epiphyses, bone age calculation, and structured reporting—the system helps physicians enhance workflow efficiency and diagnostic accuracy in bone age assessment, ultimately benefiting patients.

Stroke is an acute cerebrovascular disease and currently the leading cause of death in China, as well as the primary cause of disability among Chinese adults. Characterized by high incidence, high mortality, and high disability rates, stroke requires timely medical intervention. To this end, major hospitals across China have established “green channels” to expedite emergency care for stroke patients.

During the critical, time-sensitive phase of emergency care, DeepWise’s Dr. Wise® Stroke AI-Assisted Diagnostic System 3.0 promptly detects and alerts clinicians to the location of lesions in both hemorrhagic and ischemic strokes, providing radiologists and neurologists with reliable diagnostic evidence.

Building upon lesion classification, the new version enables automated detection of the brain midline, analyzes midline-related information, and provides predictions of midline shift based on clinical guidelines. It also introduces a follow-up function that facilitates longitudinal analysis of lesions of the same category, allowing for quantitative monitoring of dynamic changes in intracranial hematomas to promptly guide clinical decision-making regarding treatment strategies.

Chest radiography is suitable for screening a variety of thoracic diseases. To address the inconsistent image quality caused by different equipment brands and models in the market, DeepWise’s Dr. Wise® Chest Radiography Computer-Aided Diagnosis System features a specially designed chest radiography quality control module, ensuring detection efficiency and accuracy from the source. Leveraging the chest radiography abnormal lesion detection algorithm developed by DeepWise Laboratory, the system employs advanced 2D deep convolutional neural network technology and proprietary rule-based algorithms to automatically identify 23 types of common abnormal lesion signs, achieving high detection rates and low false-positive rates.

The system adheres to the image interpretation habits and report-writing sequence of radiologists, categorizing abnormal findings into five major classes. It not only enables automatic detection of abnormal findings but also generates standardized intelligent reports with a single click, thereby standardizing report templates, preventing information loss, and comprehensively improving work efficiency.

Empowering Healthcare with AI: Unlocking Technological Potential, DeepWise Is Helping Hospitals Build Smart Healthcare and Truly Realize “Intelligence+.” On the Path of Future Development in AI-Healthcare Applications, DeepWise Upholds a Spirit of Innovation, Constructs Integrated Solutions for All Disease Categories, Improves Efficiency for Physicians, and Benefits a Broader Population.